Lynne Krummen

4.1k total citations · 1 hit paper
34 papers, 3.3k citations indexed

About

Lynne Krummen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Reproductive Medicine. According to data from OpenAlex, Lynne Krummen has authored 34 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Reproductive Medicine. Recurrent topics in Lynne Krummen's work include TGF-β signaling in diseases (16 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Lynne Krummen is often cited by papers focused on TGF-β signaling in diseases (16 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Lynne Krummen collaborates with scholars based in United States, Japan and France. Lynne Krummen's co-authors include Jennie P. Mather, Vanessa Chisholm, Mathias Winkler, Leonard G. Presta, Napoleone Ferrara, Y. Gloria Meng, Dana C. Andersen, Teresa K. Woodruff, Milton J. Finegold and Huan Lu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Biotechnology.

In The Last Decade

Lynne Krummen

34 papers receiving 3.1k citations

Hit Papers

Humanization of an anti-vascular endothelial growth facto... 1997 2026 2006 2016 1997 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
    1997 1.3k citations Vanessa Chisholm, Lynne Krummen et al. profile →

Peers

Lynne Krummen
Bjørn Risberg Norway
Vanessa Chisholm United States
M. Nicotra Italy
Regina S. Whitaker United States
Barry M. Kacinski United States
Diane L. Persons United States
Nicholas H. A. Terry United States
Mark Blick United States
D Delia Italy
Cornelisse Cj Netherlands
Bjørn Risberg Norway
Lynne Krummen
Citations per year, relative to Lynne Krummen Lynne Krummen (= 1×) peers Bjørn Risberg

Countries citing papers authored by Lynne Krummen

Since Specialization
Citations

This map shows the geographic impact of Lynne Krummen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne Krummen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne Krummen more than expected).

Fields of papers citing papers by Lynne Krummen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne Krummen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne Krummen. The network helps show where Lynne Krummen may publish in the future.

Co-authorship network of co-authors of Lynne Krummen

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne Krummen. A scholar is included among the top collaborators of Lynne Krummen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne Krummen. Lynne Krummen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krummen, Lynne, et al.. (2016). QbD implementation and Post Approval Lifecycle Management (PALM). Biologicals. 44(5). 332–340. 28 indexed citations
2.
Andersen, Dana C. & Lynne Krummen. (2002). Recombinant protein expression for therapeutic applications. Current Opinion in Biotechnology. 13(2). 117–123. 258 indexed citations
3.
4.
Champion, Kathleen M., David Arnott, William J. Henzel, et al.. (1999). A two-dimensional protein map of Chinese hamster ovary cells. Electrophoresis. 20(4-5). 994–1000. 38 indexed citations
5.
Papac, Damon I., John B. Briggs, Martin Gawlitzek, et al.. (1999). Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nature Biotechnology. 17(11). 1116–1121. 147 indexed citations
6.
Toppari, Jorma, Antti Kaipia, Marko Kaleva, et al.. (1998). Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels. Apmis. 106(1-6). 101–113. 30 indexed citations
7.
Moore, Alison, Lynne Krummen, & Jennie P. Mather. (1994). Inhibins, activins, their binding proteins and receptors: Interactions underlying paracrine activity in the testis. Molecular and Cellular Endocrinology. 100(1-2). 81–86. 33 indexed citations
8.
Krummen, Lynne, et al.. (1994). Localization of Inhibin and Activin Binding Sites in the Testis during Development by in Situ Ligand Binding. Biology of Reproduction. 50(4). 734–744. 65 indexed citations
9.
Petraglia, Felice, Pasquale Florio, M D Sadick, et al.. (1993). Activin A and activin B measured in maternal serum, cord blood serum andamniotic fluid during human pregnancy. Endocrine Journal. 1. 323–327. 47 indexed citations
10.
Woodruff, Teresa K., et al.. (1993). Inhibin and activin measured in human serum.. Human Reproduction. 7 indexed citations
11.
Woodruff, Teresa K., Lynne Krummen, D L Baly, et al.. (1993). Quantitative two-site enzyme-linked immunosorbent assays for inhibin A, activin A and activin B. Human Reproduction. 8(suppl 2). 133–137. 13 indexed citations
12.
Woodruff, Teresa K., et al.. (1993). Recombinant human inhibin A and recombinant human activin A regulate pituitary and ovarian function in the adult female rat.. Endocrinology. 132(6). 2332–2341. 45 indexed citations
13.
14.
Woodruff, Teresa K., Lynne Krummen, Glynis McCray, & Jennie P. Mather. (1993). In situ ligand binding of recombinant human [125I] activin-A and recombinant human [125I]inhibin-A to the adult rat ovary.. Endocrinology. 133(6). 2998–3006. 48 indexed citations
15.
Mather, Jennie P., Teresa K. Woodruff, & Lynne Krummen. (1992). Paracrine Regulation of Reproductive Function by Inhibin and Activin. Experimental Biology and Medicine. 201(1). 1–15. 144 indexed citations
16.
Baldwin, David M., Prem S. Srivastava, & Lynne Krummen. (1991). Differential Actions of Corticosterone on Luteinizing Hormone and Follicle-Stimulating Hormone Biosynthesis and Release in Cultured Rat Anterior Pituitary Cells: Interactions with Estradiol1. Biology of Reproduction. 44(6). 1040–1050. 28 indexed citations
17.
Krummen, Lynne, Beatrice S. Morelos, & Shalender Bhasin. (1990). The Role of Luteinizing Hormone in Regulation of Testicular Inhibin α and β-B Subunit Messenger RNAs in Immature and Adult Animals*. Endocrinology. 127(3). 1097–1104. 12 indexed citations
18.
Krummen, Lynne, Jorma Toppari, Beatrice S. Morelos, et al.. (1989). Regulation of Testicular Inhibin Subunit Messenger Ribonucleic Acid Levelsin Vivo: Effects of Hypophysectomy and Selective Follicle-Stimulating Hormone Replacement*. Endocrinology. 125(3). 1630–1637. 36 indexed citations
19.
Bhasin, Shalender, Lynne Krummen, Ronald S. Swerdloff, et al.. (1989). Stage Dependent Expression of Inhibin α and β-B Subunits during the Cycle of the Rat Seminiferous Epithelium*. Endocrinology. 124(2). 987–991. 65 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bjørn Risberg Breakdown of academic impact, for papers by Vanessa Chisholm Breakdown of academic impact, for papers by M. Nicotra Breakdown of academic impact, for papers by Regina S. Whitaker Breakdown of academic impact, for papers by Barry M. Kacinski Breakdown of academic impact, for papers by Diane L. Persons Breakdown of academic impact, for papers by Nicholas H. A. Terry Breakdown of academic impact, for papers by Mark Blick Breakdown of academic impact, for papers by D Delia Breakdown of academic impact, for papers by Cornelisse Cj
Rankless by CCL
2026